Hematology, Hemostasis, & Urinalysis

|4 min read

Researchers Find Breast Cancer Drug Boosts Leukemia Treatment

OHSU researchers identified new drug combination that could overcome treatment resistance in acute myeloid leukemia
Updated |2 min read

Streamlining Acute Promyelocytic Leukemia Diagnosis: The Case for a Unified PML-RARA Testing Solution

Detecting all PML-RARA fusion isoforms in a single assay could help simplify the diagnostic workflow for acute promyelocytic leukemia
|3 min read

9 Metrics to Guide a Patient-Centric Blood Testing Process

How labs can assess performance, enhance patient engagement, and build trust through a patient-focused approach to blood testing
|2 min read

ADLM Releases New Guidance on Coagulation Testing to Improve Care for Patients on Blood Thinners

The new guidelines will help ensure that patients taking blood thinners still receive accurate diagnoses and effective treatment
|2 min read

Why Blood Management Is Especially Important During Times of Anticipated High Trauma

Innovative diagnostics and patient blood management strategies are redefining how hospitals respond to seasonal blood shortages
|3 min read

High Levels of Short-Chain PFAS Found in Wilmington Residents’ Blood

Ultrashort-chain PFAS have been little studied in humans, once dismissed as non-bioaccumulative and undetectable in blood
|2 min read

Where Sustainability Meets Security: Improving Blood Banking Cold Storage Equipment

Blood banks are increasingly seeking more sustainable options that can still meet regulatory requirements
|2 min read

New Push for Routine Urine Screening at Age 3 to Detect Alport Syndrome

Universal early-age urinalysis may be an apt means for both better prognoses and reduced costs of medical care
|1 min read

Tailoring Digital Pathology to Lab Needs

A framework for designing digital pathology systems that balance throughput, budgets, and turnaround times
Sponsored by
|1 min read

What to Expect From Digital Pathology

Review findings from a proof-of-concept study evaluating the performance of an end-to-end digital pathology workflow for high-volume labs
Sponsored by
Updated |2 min read

AliveDx's MosaiQ® Platform Registered with FDA as Class II 510(k) Exempt, Enabling US Labs to Adopt High-Throughput Automated Immunoassay Testing

MosaiQ is a next-gen immunoassay platform delivering automated, multiplexed testing and actionable insights for complex conditions
Page 2 of 42